Dr. Nolan Williams is a Professor of Psychiatry at Stanford University and the Director of the Stanford Brain Stimulation Lab. He is triple certified in psychiatry, neurology and neuropsychiatry. Dr. Williams' work has resulted in an FDA clearance for the world's first non-invasive, rapid-acting neuromodulation approach for treatment-resistant depression. He has published papers in high-impact peer-reviewed journals including Brain, American Journal of Psychiatry, and the Proceedings of the National Academy of Science.
In today's episode we discuss the Stanford Neuromodulation Therapy for treatment resistant depression, the differences between neurology and psychiatry, the first randomised trial in medicine, the problem with the chemical imbalance theory of depression, the suppression of psychedelics research, and the potential utility of psychedelics such as psilocybin, ketamine, MDMA and ibogaine.
You can learn more about Dr. Williams here:
https://profiles.stanford.edu/nolan-williams
Interviewed by Dr. Alex Curmi - Give feedback here - thinkingmindpodcast@gmail.com - Follow us here: Twitter @thinkingmindpod Instagram @thinkingmindpodcast
If you would like to enquire about an online psychotherapy appointment with Dr. Alex, you can email - alexcurmitherapy@gmail.com
Join Our Mailing List! - https://thinkingmindpod.aidaform.com/mailinglistsignup
SUPPORT: buymeacoffee.com/thinkingmind
Give feedback here - thinkingmindpodcast@gmail.com Follow us here: Twitter @thinkingmindpod Instagram @thinkingmindpodcast
Published on 2 years, 3 months ago
If you like Podbriefly.com, please consider donating to support the ongoing development.
Donate